Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.verified

HEPA

Price:

$0.4998

Market Cap:

$3.48M

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH), as well as in nonclinical studies to reduce liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH, and has demonstrated antiviral activities towards hepatitis B, C, and D viruses through several mechanisms. The co...[Read more]

Industry

Biotechnology

IPO Date

2014-02-10

Stock Exchange

NASDAQ

Ticker

HEPA

The Current Ratio as of December 2024 (TTM) for Hepion Pharmaceuticals, Inc. (HEPA) is 1.30

According to Hepion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.30. This represents a change of -67.94% compared to the average of 4.05 of the last 4 quarters.

Hepion Pharmaceuticals, Inc. (HEPA) Historical Current Ratio (quarterly & annually)

How has HEPA Current Ratio performed in the past?

The mean historical Current Ratio of Hepion Pharmaceuticals, Inc. over the last ten years is 5.25. The current 1.30 Current Ratio has changed 2.37% with respect to the historical average. Over the past ten years (40 quarters), HEPA's Current Ratio was at its highest in in the March 2021 quarter at 41.06. The Current Ratio was at its lowest in in the June 2018 quarter at 0.55.

Quarterly (TTM)
Annual

Average

5.25

Median

3.89

Minimum

1.04

Maximum

11.88

Hepion Pharmaceuticals, Inc. (HEPA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Hepion Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 758.41%

Maximum Annual Current Ratio = 11.88

Minimum Annual Increase = -55.27%

Minimum Annual Current Ratio = 1.04

Quarterly (TTM)
Annual
YearCurrent RatioChange
20233.31-53.86%
20227.16-39.67%
202111.8829.85%
20209.152.30%
20198.94758.41%
20181.04-55.27%
20172.33-48.03%
20174.48188.46%
20161.55-42.61%
20152.71-37.38%

Hepion Pharmaceuticals, Inc. (HEPA) Average Current Ratio

How has HEPA Current Ratio performed in the past?

The current Current Ratio of Hepion Pharmaceuticals, Inc. (HEPA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

7.45

5-year avg

8.09

10-year avg

5.25

Hepion Pharmaceuticals, Inc. (HEPA) Current Ratio vs. Peers

How is HEPA’s Current Ratio compared to its peers?

Hepion Pharmaceuticals, Inc.’s Current Ratio is less than Enveric Biosciences, Inc. (5.17), less than CohBar, Inc. (15.69), less than Elevation Oncology, Inc. (17.77), greater than Ocean Biomedical, Inc. (0.07), less than AVROBIO, Inc. (26.17), less than Zura Bio Limited (10.36), greater than eFFECTOR Therapeutics, Inc. (1.03),

Build a custom stock screener for Hepion Pharmaceuticals, Inc. (HEPA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hepion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hepion Pharmaceuticals, Inc. (HEPA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hepion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Hepion Pharmaceuticals, Inc.'s Current Ratio?

How is the Current Ratio calculated for Hepion Pharmaceuticals, Inc. (HEPA)?

What is the highest Current Ratio for Hepion Pharmaceuticals, Inc. (HEPA)?

What is the 3-year average Current Ratio for Hepion Pharmaceuticals, Inc. (HEPA)?

What is the 5-year average Current Ratio for Hepion Pharmaceuticals, Inc. (HEPA)?

How does the current Current Ratio for Hepion Pharmaceuticals, Inc. (HEPA) compare to its historical average?